Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials

[41] Liu J-F(2014)Management of diabetic nephropathy in older patients: a need for flexible guidelines Postgrad Med 126 171-undefined

[42] Song H-X(2021)Efficacy and safety of astragalus injection combined with Western medicine in the treatment of early diabetic nephropathy: A protocol for systematic review and meta-analysis Med (Baltim) 100 e25096-undefined

[43] Gong J(2018)Comparison of the impact of Tripterygium wilfordii Hook F and methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study Arthritis Res Ther 20 70-undefined

[44] Chen W(2013)Treatment of diabetic nephropathy with Tripterygium wilfordii Hook Fextract: a prospective, randomized, controlled clinical trial J Transl Med 11 134-undefined

[45] Feng B(2020)Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR J Formos Med Assoc 119 685-undefined

[46] Ye Z-L(2014)Effects and mechanisms of multi-glycoside of Tripterygium wilfordii improving glomerular inflammatory injury by regulating p38MAPK signaling activation in diabetic nephropathy rats Zhongguo Zhong Yao Za Zhi 39 4102-undefined

[47] Yang X(2013)Inflammation and the pathogenesis of diabetic nephropathy Clin Sci 124 139e52-undefined

[48] Guo Y-Q(2020)Effects of adding Tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy Chronic Dis Transl Med 6 18-undefined

[49] Zuo Y-H(2020)Efficacy of Tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis Biosci Rep 40 BSR20202391-undefined

[50] Fan H-Y(undefined)undefined undefined undefined undefined-undefined

[41] Liu J-F(2014)Management of diabetic nephropathy in older patients: a need for flexible guidelines Postgrad Med 126 171-undefined

[42] Song H-X(2021)Efficacy and safety of astragalus injection combined with Western medicine in the treatment of early diabetic nephropathy: A protocol for systematic review and meta-analysis Med (Baltim) 100 e25096-undefined

[43] Gong J(2018)Comparison of the impact of Tripterygium wilfordii Hook F and methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study Arthritis Res Ther 20 70-undefined

[44] Chen W(2013)Treatment of diabetic nephropathy with Tripterygium wilfordii Hook Fextract: a prospective, randomized, controlled clinical trial J Transl Med 11 134-undefined

[45] Feng B(2020)Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR J Formos Med Assoc 119 685-undefined

[46] Ye Z-L(2014)Effects and mechanisms of multi-glycoside of Tripterygium wilfordii improving glomerular inflammatory injury by regulating p38MAPK signaling activation in diabetic nephropathy rats Zhongguo Zhong Yao Za Zhi 39 4102-undefined

[47] Yang X(2013)Inflammation and the pathogenesis of diabetic nephropathy Clin Sci 124 139e52-undefined

[48] Guo Y-Q(2020)Effects of adding Tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy Chronic Dis Transl Med 6 18-undefined

[49] Zuo Y-H(2020)Efficacy of Tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis Biosci Rep 40 BSR20202391-undefined

[50] Fan H-Y(undefined)undefined undefined undefined undefined-undefined